Workflow
“中药液”里涉嫌添加安眠药?官方通报
券商中国·2025-05-19 02:23

Core Viewpoint - The article discusses the investigation into a hospital in Shijiazhuang for allegedly selling a traditional Chinese medicine for insomnia that contains the controlled substance diazepam, raising concerns about drug safety and regulatory compliance [1]. Group 1: Investigation and Regulatory Response - The Shijiazhuang Qiaoxi District Market Supervision Administration has initiated an investigation into the Hebei Puzhe Medical and Health Service Co., Ltd. for the alleged addition of sleeping pills in their herbal medicine [1]. - The administration emphasizes its commitment to enhancing drug safety supervision to protect public health [1]. Group 2: Allegations and Consumer Reports - A consumer reported that after purchasing a herbal remedy for insomnia from the hospital, they experienced drowsiness, leading to tests that confirmed the presence of diazepam [1]. - Diazepam is classified as a second-class controlled substance under the Regulations on the Administration of Psychotropic Substances, with risks of dependency and addiction associated with long-term or excessive use [1]. Group 3: Hospital's Response - The on-duty doctor at Puzhe Hospital denied the allegations of adding diazepam to their products when approached by reporters [1].